Lv2
120 积分 2025-02-19 加入
带状疱疹的临床和流行病学特征综述
19天前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
1个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1个月前
已完结
原发性IgA肾病管理和治疗中国专家共识
1个月前
已完结
皖公网安备34019202002308
